# The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease

> **NCT02133534** · PHASE4 · TERMINATED · sponsor: **Duke University** · enrollment: 1 (actual)

## Conditions studied

- Chronic Kidney Disease
- High Cholesterol

## Interventions

- **DRUG:** Atorvastatin

## Key facts

- **NCT ID:** NCT02133534
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-02
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 1 (ACTUAL)
- **Why stopped:** failure to enroll
- **Last updated:** 2014-07-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02133534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02133534, "The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02133534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
